Matches in Nanopublications for { ?s ?p "[We assessed the safety and activity of the oral BRAF inhibitor vemurafenib in patients with hairy-cell leukemia that had relapsed after treatment with a purine analogue or who had disease that was refractory to purine analogues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[We assessed the safety and activity of the oral BRAF inhibitor vemurafenib in patients with hairy-cell leukemia that had relapsed after treatment with a purine analogue or who had disease that was refractory to purine analogues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1293888.RAJ0mg4m_QYe8yaeOSnjmtWwibCxMe1sNF_eF9-s6NXAA130_assertion description "[We assessed the safety and activity of the oral BRAF inhibitor vemurafenib in patients with hairy-cell leukemia that had relapsed after treatment with a purine analogue or who had disease that was refractory to purine analogues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293888.RAJ0mg4m_QYe8yaeOSnjmtWwibCxMe1sNF_eF9-s6NXAA130_provenance.